Koyfin Home > Directory > Health Care > Kindred Biosciences > EV / EBITDA (ntm)

Kindred Biosciences EV / EBITDA (ntm) Chart (KIN)

Kindred Biosciences annual/quarterly EV / EBITDA (ntm) from 2015 to 2016. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Kindred Biosciences EV / EBITDA (ntm) for the quarter ending June 06, 2016 was 0.12 a 43.08% increase of 0.05 year over year
  • Kindred Biosciences EV / EBITDA (ntm) for the last 12 months ending June 06, 2016 was 0.12 a 43.08% increase of 0.05 year over year
  • Kindred Biosciences Annual EV / EBITDA (ntm) for 2016 was 0.12 a -40.94% decrease of -0.05 from 2015
  • Kindred Biosciences Annual EV / EBITDA (ntm) for 2016 was 0.17 a 96.83% increase of 0.16 from 2015
  • Kindred Biosciences Annual EV / EBITDA (ntm) for 2016 was 0.01 a -1,174.81% decrease of -0.06 from 2015
Other Valuation Metrics:
  • Kindred Biosciences Market Cap for the quarter ending March 03, 2018 was $244m a 17.27% increase of 42m year over year
  • Kindred Biosciences Price / Book for the quarter ending March 03, 2018 was 2.88 a 2.67% increase of 0.08 year over year
  • Kindred Biosciences Enterprise Value for the quarter ending March 03, 2018 was $163m a 16.10% increase of 26m year over year
View Chart On Koyfin

Quarterly KIN EV / EBITDA (ntm) Data

06/20160.12
06/20160.17
06/20160.01
05/20160.07
05/20160.17
05/20160.11
05/20160.04
04/20160.00
04/20160.03
04/20160.01

Annual KIN EV / EBITDA (ntm) Data

20160.12
20160.17
20160.01
20160.07
20160.17
20160.11
20160.04
20160.00
20160.03
20160.01